Brazil: Former Brazilian President Jair Bolsonaro has been diagnosed with early-stage skin cancer, his medical team said Wednesday. The diagnosis followed his discharge from the hospital earlier the same day after a brief health scare.


Brazil: Ex-Brazilian President Jair Bolsonaro Diagnosed With Early-Stage Skin Cancer

The former U.S. President Joe Biden recently underwent Mohs surgery to remove skin cancer lesions, a spokesperson confirmed. This comes just months after Biden was diagnosed with prostate cancer. Let's dig deep into what Mohs surgery is, how it works, and why it is considered highly effective in treating skin cancer.


Joe Biden Undergoes Skin Cancer Procedure: What is Mohs Surgery? 

A recent study has found that a common form of human papillomavirus (HPV), named Beta-HPV, might be more harmful than believed until now. Beta-HPV, which was once considered a rare contributor to skin cancer by intensifying UV damage, may in fact play a more direct role in driving cancer growth by actually hijacking the body’s cells. The study found that the virus can take over the body’s cells and promote tumour growth. These findings came from examining a 34-year-old woman who had recurring cutaneous squamous cell carcinoma (cSCC) on her forehead, despite undergoing surgeries and immunotherapy.&nbsp;A deeper genetic analysis revealed something surprising: the beta-HPV had actually integrated itself into the DNA of the woman’s tumor and was producing viral proteins that helped the cancer thrive. The woman had an inherited immune disorder, one that prevented her T cells from attacking HPV.Until now, beta-HPV was never found to have integrated into cellular DNA.&nbsp;“It suggests that there may be more people out there with aggressive forms of cSCC who have an underlying immune defect and could benefit from treatments targeting the immune system,” said immunologist Andrea Lisco from the US National Institute of Allergy and Infectious Diseases (NIAID).The research has been published in The New England Journal of Medicine.&nbsp;Further tests revealed that the woman’s immune system could still repair DNA damage from UV radiation, the typical cause of cSCC, but the impairment of her T cells meant the beta-HPV could invade her skin cells and trigger the formation of cancer.&nbsp;The immunocompromised woman was also being treated for other HPV-related illnesses, including warts on the skin and in the mouth.Once the cause was found, she received a bone marrow stem cell transplant to replace her dysfunctional T cells with healthy ones. This cleared up the aggressive skin cancer and her other HPV-caused issues, none of which returned in a three-year follow-up period.&nbsp;“This discovery and successful outcome would not have been possible without the combined expertise of virologists, immunologists, oncologists, and transplant specialists, all working under the same roof,” says Lisco.&nbsp;The study shows that there are other factors at work too besides UV radiation as a cause of skin cancer. In cases of weakened immune systems like this, which are rare, even benign viruses can have devastating effects.The finding emphasises the need for targeted and personalised cancer treatments that may well be more effective than conventional and generic approaches.&nbsp;“This discovery could completely change how we think about the development, and consequently the treatment, of cSCC in people who have a health condition that compromises immune function,” says Lisco.

The woman had an inherited immune disorder, one that prevented her T cells from attacking HPV, and the finding emphasises the need for targeted and personalised cancer treatments that may well be more effective than conventional and generic approaches.

A recent study has found that a common form of human papillomavirus (HPV), named Beta-HPV, might be more harmful than believed until now. Beta-HPV, which was once considered a rare contributor to skin cancer by intensifying UV damage, may in fact play a more direct role in driving cancer growth by actually hijacking the body’s cells. The study found that the virus can take over the body’s cells and promote tumour growth. These findings came from examining a 34-year-old woman who had recurring cutaneous squamous cell carcinoma (cSCC) on her forehead, despite undergoing surgeries and immunotherapy. A deeper genetic analysis revealed something surprising: the beta-HPV had actually integrated itself into the DNA of the woman’s tumor and was producing viral proteins that helped the cancer thrive. The woman had an inherited immune disorder, one that prevented her T cells from attacking HPV. Until now, beta-HPV was never found to have integrated into cellular DNA. “It suggests that there may be more people out there with aggressive forms of cSCC who have an underlying immune defect and could benefit from treatments targeting the immune system,” said immunologist Andrea Lisco from the US National Institute of Allergy and Infectious Diseases (NIAID). The research has been published in The New England Journal of Medicine. Further tests revealed that the woman’s immune system could still repair DNA damage from UV radiation, the typical cause of cSCC, but the impairment of her T cells meant the beta-HPV could invade her skin cells and trigger the formation of cancer. The immunocompromised woman was also being treated for other HPV-related illnesses, including warts on the skin and in the mouth. Once the cause was found, she received a bone marrow stem cell transplant to replace her dysfunctional T cells with healthy ones. This cleared up the aggressive skin cancer and her other HPV-caused issues, none of which returned in a three-year follow-up period. “This discovery and successful outcome would not have been possible without the combined expertise of virologists, immunologists, oncologists, and transplant specialists, all working under the same roof,” says Lisco. The study shows that there are other factors at work too besides UV radiation as a cause of skin cancer. In cases of weakened immune systems like this, which are rare, even benign viruses can have devastating effects. The finding emphasises the need for targeted and personalised cancer treatments that may well be more effective than conventional and generic approaches. “This discovery could completely change how we think about the development, and consequently the treatment, of cSCC in people who have a health condition that compromises immune function,” says Lisco.

The woman had an inherited immune disorder, one that prevented her T cells from attacking HPV, and the finding emphasises the need for targeted and personalised cancer treatments that may well be more effective than conventional and generic approaches.

Scientists find cause of one of the world’s most common cancers, ignite hope

Joe Biden on Friday (May 30) delivered his first speech since being diagnosed earlier this month with an aggressive form of prostate cancer that has spread to his bones. Speaking in Delaware, the former US president honoured fallen soldiers during a Memorial Day week event.<h2>Honouring sacrifice and defending democracy</h2>In New Castle, Biden linked their sacrifice to the responsibility Americans have today. “They are not asking us to risk our lives, they are asking us to stay true to what America stands for,” he said. “They are not asking us to do their jobs, they are asking us do our jobs – to protect our nation, in our time, now, to defend democracy.”Though he didn’t mention Donald Trump by name, Biden’s remarks came after the current Republican president gave a self-focused Memorial Day address. Biden’s words stood in contrast, with an emphasis on national duty and unity.<h2>Avoiding talk of Trump and treatment</h2>Throughout the speech, Biden did not speak about Trump or his recent push for more presidential power, which critics say threatens American democracy. Nor did he refer to his own illness during the address.Still, he sounded passionate and strong. The speech also came as his family marked ten years since the death of his son Beau, who passed away from brain cancer at the age of 46.<h2>Optimism despite aggressive cancer</h2>After the event, Biden spoke briefly with reporters and confirmed he is already receiving treatment for the disease. “All the folks are very optimistic… the expectation is we are going to be able to beat this,” he said.He described the treatment as “one particular pill” taken daily and added, “It’s not in any organs, my bones are strong.” Biden shared that he is under the care of a top surgeon who himself survived prostate cancer thirty years ago.<h2>At a crossroads for America</h2>Biden didn’t hold back when discussing the challenges the country faces today. “We’re at a really difficult moment, not just Americans, the world,” he said, calling this “an inflection point” where decisions made now will shape the next two decades.He also expressed pride in his time as president, saying, “I’m very proud. I’ll put my record as president against any president at all.”

In New Castle, Biden linked their sacrifice to the responsibility Americans have today. “They are not asking us to risk our lives, they are asking us to stay true to what America stands for,” he said.

Joe Biden on Friday (May 30) delivered his first speech since being diagnosed earlier this month with an aggressive form of prostate cancer that has spread to his bones. Speaking in Delaware, the former US president honoured fallen soldiers during a Memorial Day week event. Honouring sacrifice and defending democracy In New Castle, Biden linked their sacrifice to the responsibility Americans have today. “They are not asking us to risk our lives, they are asking us to stay true to what America stands for,” he said. “They are not asking us to do their jobs, they are asking us do our jobs – to protect our nation, in our time, now, to defend democracy.” Though he didn’t mention Donald Trump by name, Biden’s remarks came after the current Republican president gave a self-focused Memorial Day address. Biden’s words stood in contrast, with an emphasis on national duty and unity. Avoiding talk of Trump and treatment Throughout the speech, Biden did not speak about Trump or his recent push for more presidential power, which critics say threatens American democracy. Nor did he refer to his own illness during the address. Still, he sounded passionate and strong. The speech also came as his family marked ten years since the death of his son Beau, who passed away from brain cancer at the age of 46. Optimism despite aggressive cancer After the event, Biden spoke briefly with reporters and confirmed he is already receiving treatment for the disease. “All the folks are very optimistic… the expectation is we are going to be able to beat this,” he said. He described the treatment as “one particular pill” taken daily and added, “It’s not in any organs, my bones are strong.” Biden shared that he is under the care of a top surgeon who himself survived prostate cancer thirty years ago. At a crossroads for America Biden didn’t hold back when discussing the challenges the country faces today. “We’re at a really difficult moment, not just Americans, the world,” he said, calling this “an inflection point” where decisions made now will shape the next two decades. He also expressed pride in his time as president, saying, “I’m very proud. I’ll put my record as president against any president at all.”

In New Castle, Biden linked their sacrifice to the responsibility Americans have today. “They are not asking us to risk our lives, they are asking us to stay true to what America stands for,” he said.

‘My bones are strong’: Biden avoids Trump, focuses  on democracy in first speech after cancer diagnosis

Israeli firm has developed a groundbreaking technology that can detect four major types of cancer - lung, breast, prostate, and colon - which account for nearly 50% of global cancer cases. The innovative method is patented in the US.

Dogs: The animal detectives changing medicine

The United Kingdom's National Health Services, the NHS, have rolled out a super jab that can treat up to 15 types of cancers, drastically cutting down treatment time from an hour to just 5 minutes.

Fast-track cancer treatment starts in England, nivolumab injection revolutionises cancer care in UK

In a major breakthrough, NHS is set to roll out a new &lsquo;super jab&rsquo; that will allow cancer patients to be treated with just one injection for 15 different types of the disease.
The new treatment, that will take just 15 minutes, will allow patients to receive the immunotherapy in a vaccine, called nivolumab, instead or spending an hour on an IV drip.
Also read | <a href="https://www.wionews.com/science-tech/booze-cigs-and-lazying-around-start-triggering-health-problems-exactly-at-this-age-9001891">Booze, cigs and lazing around start triggering health problems exactly at THIS age</a>
England becomes the first European country to offer the treatment that will be given to around 1,200 patients a month to receive it for 15 different types of cancer, including bladder, skin and oesophageal cancer.
The drug, which is a monoclonal antibody, works by clinging to a protein called PD-1 on an immune cell called T-cell. It blocks cancer cells from switching off T-cells, which enables the immune system to seek out and destroy cancer cells.
Also read | <a href="https://www.wionews.com/science-tech/is-your-sleep-position-slowly-killing-you-you-might-be-at-risk-of-heart-disease-and-diabetes-8974773">Your sleep position can tell if you are at risk of heart disease and diabetes</a>
According to NHS England, the jab will be rolled out to eligible patients next month. It is expected that the new milestone vaccine will save around 1,000 hours of treatment time for patients and medical workers every month.
<h2>&lsquo;A significant advancement in cancer treatment&rsquo;</h2>
&ldquo;This treatment is used for 15 different types of the disease, so it will free up thousands of valuable clinicians&rsquo; time every year, allowing teams to treat even more patients and helping hospital capacity,&rdquo; said Professor Peter Johnson, NHS England National Clinical Director for Cancer.
Also read | <a href="https://www.wionews.com/world/towards-a-safer-world-after-three-years-of-talks-who-countries-finally-agree-on-how-to-tackle-future-pandemics-covid-19-covid-coronavirus-pandemic-8970529">'Towards a safer world': After three years of talks, WHO countries finally agree on how to tackle future pandemics</a> 
&ldquo;And this is just the latest development in the NHS&rsquo;s ongoing commitment to provide patients with the latest cancer therapies and treatment options that truly transform lives,&rdquo; he added.
Minister for Public Health and Prevention Ashley Dalton said, &ldquo;Britain is a hotbed of innovation, masterminding the newest tech and medical inventions to help people navigate illness. A new jab that fastens up cancer treatment is a prime example of this, so it&rsquo;s fantastic to see that cancer patients in England will be among the first in Europe to benefit.&rdquo;
Watch | 'Towards a safer world': After three years of talks, WHO countries finally agree on how to tackle future pandemics 
<iframe width="600" height="auto" style="width: 100%; aspect-ratio: 4/3;" allowfullscreen="allowfullscreen" class="external-video publive-iframes-block" src="https://cdn.thepublive.com/wion/static/kaltura_player/wion_video_player_iframe.html?thumbnail=wion/media/post_attachments/screenshot/2004_WION_cancer_9pm/00000002.jpg&amp;videourl=https://vodakm.zeenews.com/vod/WION/2004_WION_cancer_9pm.mp4/index.m3u8&amp;duration=105&amp;tags=wion, wion news, world news, world news latest, viral" title="Cancer prevention breakthrough: Vitamin D can help in colorectal cancer prevention" id="PL_iframe_block-ma52iti1-ns5rtxvm-r1qq96dh"></iframe>
&ldquo;With cancer medicines getting better all the time, this government will ensure that NHS patients are among the first to access the latest treatments and technology,&rdquo; Dalton said.
James Richardson, Clinical Pharmacist and National Specialty Adviser for Cancer Drugs, said, &ldquo;I am delighted that NHS patients across England will soon be able to benefit from this quicker-to-administer, effective treatment, that can be used to treat a range of cancer types, including skin cancer and solid tumours originating in the kidneys. This is a significant advancement in cancer treatment, with the potential to improve the lives of thousands of patients each month.&rdquo;

The new treatment, that will take just 15 minutes, will allow patients to receive the immunotherapy in a vaccine, called nivolumab, instead or spending an hour on an IV drip. Science & tech

In a major breakthrough, NHS is set to roll out a new ‘super jab’ that will allow cancer patients to be treated with just one injection for 15 different types of the disease. The new treatment, that will take just 15 minutes, will allow patients to receive the immunotherapy in a vaccine, called nivolumab, instead or spending an hour on an IV drip. Also read | Booze, cigs and lazing around start triggering health problems exactly at THIS age England becomes the first European country to offer the treatment that will be given to around 1,200 patients a month to receive it for 15 different types of cancer, including bladder, skin and oesophageal cancer. The drug, which is a monoclonal antibody, works by clinging to a protein called PD-1 on an immune cell called T-cell. It blocks cancer cells from switching off T-cells, which enables the immune system to seek out and destroy cancer cells. Also read | Your sleep position can tell if you are at risk of heart disease and diabetes According to NHS England, the jab will be rolled out to eligible patients next month. It is expected that the new milestone vaccine will save around 1,000 hours of treatment time for patients and medical workers every month. ‘A significant advancement in cancer treatment’ “This treatment is used for 15 different types of the disease, so it will free up thousands of valuable clinicians’ time every year, allowing teams to treat even more patients and helping hospital capacity,” said Professor Peter Johnson, NHS England National Clinical Director for Cancer. Also read | 'Towards a safer world': After three years of talks, WHO countries finally agree on how to tackle future pandemics “And this is just the latest development in the NHS’s ongoing commitment to provide patients with the latest cancer therapies and treatment options that truly transform lives,” he added. Minister for Public Health and Prevention Ashley Dalton said, “Britain is a hotbed of innovation, masterminding the newest tech and medical inventions to help people navigate illness. A new jab that fastens up cancer treatment is a prime example of this, so it’s fantastic to see that cancer patients in England will be among the first in Europe to benefit.” Watch | 'Towards a safer world': After three years of talks, WHO countries finally agree on how to tackle future pandemics “With cancer medicines getting better all the time, this government will ensure that NHS patients are among the first to access the latest treatments and technology,” Dalton said. James Richardson, Clinical Pharmacist and National Specialty Adviser for Cancer Drugs, said, “I am delighted that NHS patients across England will soon be able to benefit from this quicker-to-administer, effective treatment, that can be used to treat a range of cancer types, including skin cancer and solid tumours originating in the kidneys. This is a significant advancement in cancer treatment, with the potential to improve the lives of thousands of patients each month.”

Cancer treatment with just one vaccine: NHS rolls out 5-minute ‘super-jab’ that will ‘truly transform lives’

Six staff members of a Massachusetts hospital working on the same floor mysteriously developed brain tumours one after the other. The tumour cases at the Newton-Wellesley Hospital were first reported in early April by the local media outlet WBZ. The hospital started an investigation in December last year and claims there is no &ldquo;environmental risk&rdquo; behind the cases.
The affected nurses work on the fifth floor maternity unit of the hospital. The sixth case was announced by the Department of Occupational Health and Safety (OHS) at Mass General Brigham, the parent system of Newton-Wellesley.
The probe started when five cases of benign brain tumours started to emerge among the nurses. Patients and families were informed about the sixth case in a letter sent by the OHS, the Boston Herald reported.
Also Read: <a href="https://www.wionews.com/world/hamas-hostage-survivor-noa-argamani-named-in-times-most-influential-people-list-8970998" rel="dofollow noopener" target="_blank">Hamas hostage survivor Noa Argamani named in TIME's most influential people list</a>
"OHS has identified six staff members who have worked for varying durations on the fifth floor and report developing benign (non-cancerous) brain tumours,&rdquo; Ellen Moloney, president and COO of Mass General Brigham/Newton-Wellesley Hospital, wrote, according to the Herald.
Massachusetts Nurses Association is still looking into the matter to try and understand what could be the reason behind mass tumours.
Meanwhile, the OHS says it is yet to find a common link between the tumours. &ldquo;While the OHS investigation is ongoing, we have found no evidence that these medical conditions were caused by the work environment,&rdquo; the letter stated.
<h2>Carcinogenic toxins in the environment can cause tumours</h2>
Notably, carcinogenic toxins can often accumulate in a single source accessed by different people and cause brain tumours.&nbsp;
Also Read: <a href="https://www.wionews.com/world/musk-solicits-women-on-x-to-have-his-babies-who-he-calls-his-legion-report-8970549" rel="dofollow noopener" target="_blank">Musk donated sperm to Japanese influencer; building 'legion' of babies using his 'harem': Report</a>
Even though hospital authorities have not found a common cause, the hospital staff thinks otherwise. They think that not just these tumours, but other illnesses among staff members can also likely be attributed to the factor that is still a secret.
The Massachusetts Nurse Association told the Herald that it will continue to investigate the matter to reach the root cause of the tumours. It added that the hospital's investigation was not comprehensive and that something seems to be wrong at Newton-Wellesley Hospital.
The probe will continue till the end of the month, when the union will make its findings public.

Six nurses at a Massachusetts hospital have developed brain tumours one after the other. The hospital claims there is no environmental cause behind them. World Trending

Six staff members of a Massachusetts hospital working on the same floor mysteriously developed brain tumours one after the other. The tumour cases at the Newton-Wellesley Hospital were first reported in early April by the local media outlet WBZ. The hospital started an investigation in December last year and claims there is no “environmental risk” behind the cases. The affected nurses work on the fifth floor maternity unit of the hospital. The sixth case was announced by the Department of Occupational Health and Safety (OHS) at Mass General Brigham, the parent system of Newton-Wellesley. The probe started when five cases of benign brain tumours started to emerge among the nurses. Patients and families were informed about the sixth case in a letter sent by the OHS, the Boston Herald reported. Also Read: Hamas hostage survivor Noa Argamani named in TIME's most influential people list "OHS has identified six staff members who have worked for varying durations on the fifth floor and report developing benign (non-cancerous) brain tumours,” Ellen Moloney, president and COO of Mass General Brigham/Newton-Wellesley Hospital, wrote, according to the Herald. Massachusetts Nurses Association is still looking into the matter to try and understand what could be the reason behind mass tumours. Meanwhile, the OHS says it is yet to find a common link between the tumours. “While the OHS investigation is ongoing, we have found no evidence that these medical conditions were caused by the work environment,” the letter stated. Carcinogenic toxins in the environment can cause tumours Notably, carcinogenic toxins can often accumulate in a single source accessed by different people and cause brain tumours. Also Read: Musk donated sperm to Japanese influencer; building 'legion' of babies using his 'harem': Report Even though hospital authorities have not found a common cause, the hospital staff thinks otherwise. They think that not just these tumours, but other illnesses among staff members can also likely be attributed to the factor that is still a secret. The Massachusetts Nurse Association told the Herald that it will continue to investigate the matter to reach the root cause of the tumours. It added that the hospital's investigation was not comprehensive and that something seems to be wrong at Newton-Wellesley Hospital. The probe will continue till the end of the month, when the union will make its findings public.

Six nurses of one hospital working on same floor develop brain tumours one after the other

Researchers have finally found a way to breach the blood-brain barrier and deliver anti-inflammatory medicine across in a huge development that opens the door to potential treatments for a range of serious neurological conditions like Alzheimer&rsquo;s disease, multiple sclerosis, Parkinson&rsquo;s disease, and cancer cachexia.
Oregon State University researchers found a way to get anti-inflammatory medicine across the blood-brain barrier by using specially engineered nanoparticles, tiny bits about 100 billionths of a metre. The team deployed the dual peptide-functionalised polymeric nanocarriers and delivered a drug that inhibits a key protein associated with inflammation to the intended destination, the hypothalamus of the brain, in a mouse model, said a ScienceDaily report. Also Read | <a href="https://www.wionews.com/science-technology/now-a-simple-blood-test-could-detect-parkinsons-disease-long-before-symptoms-emerge-8957415">Now a simple blood test could detect Parkinson&rsquo;s disease long before symptoms emerge</a> &ldquo;Our work presents a significant breakthrough,&rdquo; said Oleh Taratula, professor in the OSU College of Pharmacy. The findings were published in Advanced Healthcare Materials on April 9. The hypothalamus is a vital part of the brain just below the thalamus and above the brainstem and helps maintain homeostasis&mdash;the body&rsquo;s internal balance. It regulates the body temperature, manages sleep cycles, hormone production, and emotional responses, besides controlling hunger and thirst. In the study, researchers specifically looked at the hypothalamus as it is linked to cachexia, a metabolic syndrome that leads to involuntary weight loss and muscle wasting, often associated with cancers of the ovaries, stomach, lungs, and pancreas and other chronic conditions such as renal failure, cystic fibrosis, Crohn&rsquo;s disease, rheumatoid arthritis, and HIV. People with cachexia lose weight even if they eat. The debilitating syndrome affects up to 80% of advanced cancer patients and kills as many as 30% of the cancer patients it afflicts. &ldquo;Inflammation of the hypothalamus plays a pivotal role in dysregulating those patients' appetite and metabolism,&rdquo; Taratula said. &ldquo;As cachexia progresses, it significantly impacts quality of life, treatment tolerance and overall survival chances.&rdquo; The systemic delivery of anti-inflammatory agents, including the IRAK4 inhibitors used in this research, to the hypothalamus presents significant challenges, mainly because of the restrictive nature of the blood-brain barrier, Taratula added.
Also Read |&nbsp;<a href="https://www.wionews.com/world/russia-seeking-to-deploy-nuclear-weapons-in-space-warns-nato-chief-8957098" rel="dofollow noopener" target="_blank">Russia seeking to deploy nuclear weapons in space, warns NATO chief</a> The blood-brain barrier, often called BBB, is a protective shield separating the brain from the bloodstream to protect it. It is made up of tightly packed cells lining the blood vessels in the brain and controls what substances can move from the blood to the brain, allowing nutrients like oxygen and glucose to pass through while blocking toxins and pathogens, keeping the brain safe from infections and damage. But in this role, it also denies entry to therapeutic agents. &ldquo;An additional hurdle, even if you can get through the BBB to the hypothalamus, is hitting the bullseye within the hypothalamus -- the activated microglia cells that act as key mediators of inflammation,&rdquo; he said, adding, &ldquo;Our nanocarriers show a dual-targeting capability, and once in the microglia, drug release is triggered by elevated intracellular glutathione levels. We demonstrated, for the first time, that nanocarriers can successfully deliver an IRAK4 inhibitor to the hypothalamus of mice with cancer cachexia.&rdquo; The results were promising as the team observed substantial reductions in key inflammatory markers in the hypothalamus, which led to a 94% increase in food intake and significantly preserved body weight and muscle mass.&nbsp; The implications extend far beyond cancer cachexia, Taratula added. &ldquo;The nanoplatform&rsquo;s ability to deliver therapeutics across the BBB and target microglia opens new possibilities for treating neurological conditions characterised by brain inflammation, including Alzheimer&rsquo;s disease and multiple sclerosis,&rdquo; he said. In the study, Taratula was joined by College of Pharmacy colleagues Yoon Tae Goo, Vladislav Grigoriev, Tetiana Korzun, Kongbrailatpam Shitaljit Sharma, Prem Singh and Olena Taratula, and by Daniel Marks from Endevica Bio.

Science & Technology | World: People with cachexia lose weight even if they eat. The debilitating syndrome affects up to 80% of advanced cancer patients and kills as many as 30% of the cancer patients it afflicts.

Researchers have finally found a way to breach the blood-brain barrier and deliver anti-inflammatory medicine across in a huge development that opens the door to potential treatments for a range of serious neurological conditions like Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and cancer cachexia. Oregon State University researchers found a way to get anti-inflammatory medicine across the blood-brain barrier by using specially engineered nanoparticles, tiny bits about 100 billionths of a metre. The team deployed the dual peptide-functionalised polymeric nanocarriers and delivered a drug that inhibits a key protein associated with inflammation to the intended destination, the hypothalamus of the brain, in a mouse model, said a ScienceDaily report. Also Read | Now a simple blood test could detect Parkinson’s disease long before symptoms emerge “Our work presents a significant breakthrough,” said Oleh Taratula, professor in the OSU College of Pharmacy. The findings were published in Advanced Healthcare Materials on April 9. The hypothalamus is a vital part of the brain just below the thalamus and above the brainstem and helps maintain homeostasis—the body’s internal balance. It regulates the body temperature, manages sleep cycles, hormone production, and emotional responses, besides controlling hunger and thirst. In the study, researchers specifically looked at the hypothalamus as it is linked to cachexia, a metabolic syndrome that leads to involuntary weight loss and muscle wasting, often associated with cancers of the ovaries, stomach, lungs, and pancreas and other chronic conditions such as renal failure, cystic fibrosis, Crohn’s disease, rheumatoid arthritis, and HIV. People with cachexia lose weight even if they eat. The debilitating syndrome affects up to 80% of advanced cancer patients and kills as many as 30% of the cancer patients it afflicts. “Inflammation of the hypothalamus plays a pivotal role in dysregulating those patients' appetite and metabolism,” Taratula said. “As cachexia progresses, it significantly impacts quality of life, treatment tolerance and overall survival chances.” The systemic delivery of anti-inflammatory agents, including the IRAK4 inhibitors used in this research, to the hypothalamus presents significant challenges, mainly because of the restrictive nature of the blood-brain barrier, Taratula added. Also Read | Russia seeking to deploy nuclear weapons in space, warns NATO chief The blood-brain barrier, often called BBB, is a protective shield separating the brain from the bloodstream to protect it. It is made up of tightly packed cells lining the blood vessels in the brain and controls what substances can move from the blood to the brain, allowing nutrients like oxygen and glucose to pass through while blocking toxins and pathogens, keeping the brain safe from infections and damage. But in this role, it also denies entry to therapeutic agents. “An additional hurdle, even if you can get through the BBB to the hypothalamus, is hitting the bullseye within the hypothalamus -- the activated microglia cells that act as key mediators of inflammation,” he said, adding, “Our nanocarriers show a dual-targeting capability, and once in the microglia, drug release is triggered by elevated intracellular glutathione levels. We demonstrated, for the first time, that nanocarriers can successfully deliver an IRAK4 inhibitor to the hypothalamus of mice with cancer cachexia.” The results were promising as the team observed substantial reductions in key inflammatory markers in the hypothalamus, which led to a 94% increase in food intake and significantly preserved body weight and muscle mass. The implications extend far beyond cancer cachexia, Taratula added. “The nanoplatform’s ability to deliver therapeutics across the BBB and target microglia opens new possibilities for treating neurological conditions characterised by brain inflammation, including Alzheimer’s disease and multiple sclerosis,” he said. In the study, Taratula was joined by College of Pharmacy colleagues Yoon Tae Goo, Vladislav Grigoriev, Tetiana Korzun, Kongbrailatpam Shitaljit Sharma, Prem Singh and Olena Taratula, and by Daniel Marks from Endevica Bio.

Researchers breach brain-blood barrier, deliver medicine precisely via nanoparticles

A new drug is offering new hope for women with advanced stage of breast cancer. The drug called 'Capivasetib' has been approved for NHS funding in England. Now this targeted therapy has shown remarkable results in slowing down cancer progression and shrinking tumors in a quarter of patients. Watch in for more details!

'Capivasertib' shrinks tumours & slows cancer growth: NHS

In a major medical breakthrough, the NHS has approved Capivasertib for funding in England. Used in combination with hormone therapy, the drug has shown significant promise in clinical trials—shrinking tumours in nearly a quarter of advanced breast cancer patients. This approval brings new hope to thousands battling the disease.

NHS approves breakthrough breast cancer drug Capivasertib for use

A recent study has discovered that drinking just one can a day of sugary soda beverages can increase the risk of developing mouth cancer by five times.
The study conducted by researchers from the University of Washington was published in JAMA Otolaryngology-Head &amp; Neck Surgery on Thursday (Mar 13).&nbsp;
<h2>Rising cases of oral cancer</h2>
Amid the rising cases of oral cavity cancer, especially in young people who do not drink or smoke and have no other evident risk factors, scientists suggest that diet may play a major role.
Also read | <a href="https://www.wionews.com/science-tech/want-to-slower-your-brains-ageing-have-children-says-recent-study-8839204">Want to slow your brain's ageing? Have children, says recent study</a>
While this type of cancer was typically linked to older men who indulged in tobacco, alcohol, betel nut chewing and other common cancer threats, cancer cases related to them have been declining, especially in Western countries.
According to about 377,713 cases of oral cancer and 177,757 deaths were recorded in 2020.
Also read | <a href="https://www.wionews.com/science-tech/you-and-your-labrador-retrievers-may-share-same-gene-linked-to-obesity-study-8836704">You and your Labrador Retriever may share same gene linked to obesity: Study</a>
<h2>Oral cancer and sugary drinks</h2>
The new study highlights the potential health risks linked to regular consumption of sugary drinks as the world sees a rising trend in oral cancer cases.&nbsp;
The study examined data from over 160,000 women, finding those who consumed sugary beverages and compared them with any diagnoses of mouth cancer. They recorded 124 such cases over the period of 30 years.
Also read | <a href="https://www.wionews.com/science-tech/kissing-oral-sex-can-lead-to-dementia-scientists-reveal-you-can-catch-this-virus-in-bedroom-8858233">Kissing, oral sex can lead to dementia. Scientists reveal you can catch THIS virus in 'bedroom'</a>
The authors of the report did not name any particular brand of the sodas, lemonades and iced teas that the women consumed during the course of the study.
The analysis revealed that women who reported consuming at least one sugary beverage a day were 4.87 times more likely to have developed mouth cancer when compared to those who consumed less than one in a month.
Also read | <a href="https://www.wionews.com/science-tech/scientist-find-that-marriage-increases-the-risk-of-this-life-threatening-disease-in-men-by-62-8850287">Scientists find marriage increases the risk of THIS life-threatening disease in men by 62%</a>
While the cause remains unclear as further research is needed in the area, scientists suggested that factors like high fructose corn syrup content may be the reason behind the increased risk of disease.
(With inputs from agencies)

Science & tech | Health and wellness | The new study highlights the potential health risks linked to regular consumption of sugary drinks as the world sees a rising trend in oral cancer cases.

A recent study has discovered that drinking just one can a day of sugary soda beverages can increase the risk of developing mouth cancer by five times. The study conducted by researchers from the University of Washington was published in JAMA Otolaryngology-Head & Neck Surgery on Thursday (Mar 13). Rising cases of oral cancer Amid the rising cases of oral cavity cancer, especially in young people who do not drink or smoke and have no other evident risk factors, scientists suggest that diet may play a major role. Also read | Want to slow your brain's ageing? Have children, says recent study While this type of cancer was typically linked to older men who indulged in tobacco, alcohol, betel nut chewing and other common cancer threats, cancer cases related to them have been declining, especially in Western countries. According to about 377,713 cases of oral cancer and 177,757 deaths were recorded in 2020. Also read | You and your Labrador Retriever may share same gene linked to obesity: Study Oral cancer and sugary drinks The new study highlights the potential health risks linked to regular consumption of sugary drinks as the world sees a rising trend in oral cancer cases. The study examined data from over 160,000 women, finding those who consumed sugary beverages and compared them with any diagnoses of mouth cancer. They recorded 124 such cases over the period of 30 years. Also read | Kissing, oral sex can lead to dementia. Scientists reveal you can catch THIS virus in 'bedroom' The authors of the report did not name any particular brand of the sodas, lemonades and iced teas that the women consumed during the course of the study. The analysis revealed that women who reported consuming at least one sugary beverage a day were 4.87 times more likely to have developed mouth cancer when compared to those who consumed less than one in a month. Also read | Scientists find marriage increases the risk of THIS life-threatening disease in men by 62% While the cause remains unclear as further research is needed in the area, scientists suggested that factors like high fructose corn syrup content may be the reason behind the increased risk of disease. (With inputs from agencies)

Can sugary drinks increase risk of oral cancer? Shocking study links popular drinks with deadly disease

A recent long-term study in the US suggests that consuming yoghurt twice a week could offer protection against certain types of colorectal cancer. While previous research has hinted at yoghurt&rsquo;s benefits for gastrointestinal health, findings have been inconsistent. This new study sheds light on how yoghurt consumption may influence cancer risk.&nbsp;
<h2>Key findings</h2>
The study, published in Gut Microbes, analysed data from over 87,000 women and nearly 45,000 men, spanning over three decades. While no significant link was found between yoghurt consumption and overall colorectal cancer incidence, researchers observed a notable effect when analysing specific cancer subtypes.
Also read |<a href="https://www.wionews.com/science-tech/french-scientists-achieve-major-milestone-in-nuclear-fusion-surpassing-chinas-record-8746721"> </a><a href="https://www.wionews.com/science-tech/french-scientists-achieve-major-milestone-in-nuclear-fusion-surpassing-chinas-record-8746721">French scientists achieve major milestone in nuclear fusion, surpassing China&rsquo;s record</a>
Individuals who consumed at least two servings of yoghurt per week were found to be 20 per cent less likely to develop Bifidobacterium-positive tumours, particularly in the proximal colon, compared to those who consumed yoghurt less than once a month.
<h2>Role of Bifidobacterium in tumour growth</h2>
Bifidobacterium is a common gut microbe found in both the human intestine and yoghurt. In about 30 per cent of colorectal cancer cases, this bacterium is present in tumour tissue, particularly in aggressive forms of the disease. It appears to thrive in the low-oxygen environment of tumours, potentially leaking past the intestinal barrier into colon tissue.&nbsp;
Surprisingly, consuming more Bifidobacterium through yoghurt might help prevent this process. Early studies suggest that the bacterium may have antioxidant, anti-inflammatory, and immune-boosting effects, which could support gut health and strengthen the intestinal barrier.
Also read |<a href="https://www.wionews.com/world/first-in-the-world-london-doctors-cure-blindness-in-children-heres-how-gene-therapy-britain-doctors-8742633"> </a><a href="https://www.wionews.com/world/first-in-the-world-london-doctors-cure-blindness-in-children-heres-how-gene-therapy-britain-doctors-8742633">'First in the world': London doctors cure blindness in children born with a genetic condition</a>
<h2>Further research needed</h2>
While the findings are promising, researchers emphasise that the results are observational and require further study. Epidemiologist Andrew Chan from Massachusetts General Hospital noted that this research adds to growing evidence linking diet, gut microbiome health, and cancer risk.
The study&rsquo;s authors suggest that future research should explore the long-term effects of yoghurt consumption on colorectal cancer prevention and the underlying biological mechanisms.
&nbsp;

SCIENCE & TECH | Trending: The study, published in Gut Microbes, analysed data from over 87,000 women and nearly 45,000 men, spanning over three decades.

A recent long-term study in the US suggests that consuming yoghurt twice a week could offer protection against certain types of colorectal cancer. While previous research has hinted at yoghurt’s benefits for gastrointestinal health, findings have been inconsistent. This new study sheds light on how yoghurt consumption may influence cancer risk. Key findings The study, published in Gut Microbes, analysed data from over 87,000 women and nearly 45,000 men, spanning over three decades. While no significant link was found between yoghurt consumption and overall colorectal cancer incidence, researchers observed a notable effect when analysing specific cancer subtypes. Also read | French scientists achieve major milestone in nuclear fusion, surpassing China’s record Individuals who consumed at least two servings of yoghurt per week were found to be 20 per cent less likely to develop Bifidobacterium-positive tumours, particularly in the proximal colon, compared to those who consumed yoghurt less than once a month. Role of Bifidobacterium in tumour growth Bifidobacterium is a common gut microbe found in both the human intestine and yoghurt. In about 30 per cent of colorectal cancer cases, this bacterium is present in tumour tissue, particularly in aggressive forms of the disease. It appears to thrive in the low-oxygen environment of tumours, potentially leaking past the intestinal barrier into colon tissue. Surprisingly, consuming more Bifidobacterium through yoghurt might help prevent this process. Early studies suggest that the bacterium may have antioxidant, anti-inflammatory, and immune-boosting effects, which could support gut health and strengthen the intestinal barrier. Also read | 'First in the world': London doctors cure blindness in children born with a genetic condition Further research needed While the findings are promising, researchers emphasise that the results are observational and require further study. Epidemiologist Andrew Chan from Massachusetts General Hospital noted that this research adds to growing evidence linking diet, gut microbiome health, and cancer risk. The study’s authors suggest that future research should explore the long-term effects of yoghurt consumption on colorectal cancer prevention and the underlying biological mechanisms.

Study suggests yoghurt may help reduce risk of specific colon cancers

World Cancer Day 2025: One in nine people in India is expected to to face a cancer diagnosis during their lifetime, says Dr. Vinayak V Maka, Senior Consultant at Ramaiah Institute of Oncosciences, Ramaiah Memorial Hospital as he explained how different genders could fall at risk of cancer at some point of their lives. While lung cancer ranks the highest among males, women are more susceptible to fall at risk of developing breast cancer.&nbsp;
On World Cancer Day, we spoke to oncologists and experts of the field to understand the different treatments available for cancer today and how to make the right decision.&nbsp;
<h2>Understanding Systemic Therapies for Cancer</h2>
Medical experts suggest that there are three primary therapeutic approaches: systemic therapy which includes chemotherapy, radiotherapy, and surgery. Each method targets cancer cells through distinct mechanisms, often used in combination for best possible remission outcomes.
Dr. Vinayak explains that chemotherapy entails the use of potent drugs aimed at eliminating rapidly proliferating cancer cells. Although effective, the treatment's side effects can be profound, including significant hair loss, fatigue, and weakened immunity. Current systemic therapy protocols are often combined with other cancer treatments like immunotherapy and target therapies , tailored more specifically to different cancer types, thereby enhancing treatment accuracy and lessening overall toxicity. &nbsp;
Radiation Therapy involves exposing the patient to ionizing radiation to eradicate or inhibit the growth of malignant cells. This method allows for precise targeting, potentially reducing overall radiation exposure and treatment duration while maximizing cancer cell destruction.&nbsp;
Surgical procedures continue to be an essential component of cancer treatment, which entails the physical excision of tumors and possibly surrounding affected tissues.&nbsp;
<h2 class="gh-archive-page-post-title"><a class="gh-archive-page-post-title-link" href="https://www.wionews.com/entertainment/lifestyle/princess-of-wales-catherines-cancer-is-now-in-remission-good-news-for-royal-family-8622663" aria-label="Kate cancer update: Princess of Wales Catherine&rsquo;s cancer in remission in good news for royal family">Kate cancer update: Princess of Wales Catherine&rsquo;s cancer in remission in good news for royal family</a></h2>
Dr. Mridul Malhotra, Consultant - Medical Oncology at Manipal Hospital Dwarka in New Delhi believes that cancer treatment today has evolved significantly, integrating traditional methods with innovative approaches. While surgery can be the first line of treatment for localising cancers, it can be combined with other therapies to enhance effectiveness. Radiation, meanwhile, involves using high doses of radiation to kill cancer cells, particularly effective for localised tumors. The most common of all, chemotherapy uses drugs to kill cancer cells in a region. This can be combined with immunotherapy, including CAR-T cell therapy, which harnesses the immune system to combat cancer more effectively.
Recent advances include precision oncology, which tailors treatment based on genetic profiling of tumors, and nanomedicine enhancing drug delivery and targeting.&nbsp;
Dr. Mridul suggests using liquid biopsies as a non-invasive cancer detection method. Also, there is gene therapy which is currently being explored to modify cancer cell behavior directly. These innovations are paving the way for more personalized and effective cancer care.
<h2 class="gh-archive-page-post-title"><a class="gh-archive-page-post-title-link" href="https://www.wionews.com/entertainment/lifestyle/shocking-27-year-old-mexican-influencer-dies-after-liposuction-procedure-8683898" aria-label="Shocking! 27-year-old Mexican Influencer dies after liposuction procedure">Shocking! 27-year-old Mexican Influencer dies after liposuction procedure</a></h2>

Lifestyle News On World Cancer Day, we spoke with oncologists as they explained the major differences between different cancer treatments - radiation, surgery and chemotherapy.

World Cancer Day 2025: One in nine people in India is expected to to face a cancer diagnosis during their lifetime, says Dr. Vinayak V Maka, Senior Consultant at Ramaiah Institute of Oncosciences, Ramaiah Memorial Hospital as he explained how different genders could fall at risk of cancer at some point of their lives. While lung cancer ranks the highest among males, women are more susceptible to fall at risk of developing breast cancer. On World Cancer Day, we spoke to oncologists and experts of the field to understand the different treatments available for cancer today and how to make the right decision. Understanding Systemic Therapies for Cancer Medical experts suggest that there are three primary therapeutic approaches: systemic therapy which includes chemotherapy, radiotherapy, and surgery. Each method targets cancer cells through distinct mechanisms, often used in combination for best possible remission outcomes. Dr. Vinayak explains that chemotherapy entails the use of potent drugs aimed at eliminating rapidly proliferating cancer cells. Although effective, the treatment's side effects can be profound, including significant hair loss, fatigue, and weakened immunity. Current systemic therapy protocols are often combined with other cancer treatments like immunotherapy and target therapies , tailored more specifically to different cancer types, thereby enhancing treatment accuracy and lessening overall toxicity. Radiation Therapy involves exposing the patient to ionizing radiation to eradicate or inhibit the growth of malignant cells. This method allows for precise targeting, potentially reducing overall radiation exposure and treatment duration while maximizing cancer cell destruction. Surgical procedures continue to be an essential component of cancer treatment, which entails the physical excision of tumors and possibly surrounding affected tissues. Kate cancer update: Princess of Wales Catherine’s cancer in remission in good news for royal family Dr. Mridul Malhotra, Consultant - Medical Oncology at Manipal Hospital Dwarka in New Delhi believes that cancer treatment today has evolved significantly, integrating traditional methods with innovative approaches. While surgery can be the first line of treatment for localising cancers, it can be combined with other therapies to enhance effectiveness. Radiation, meanwhile, involves using high doses of radiation to kill cancer cells, particularly effective for localised tumors. The most common of all, chemotherapy uses drugs to kill cancer cells in a region. This can be combined with immunotherapy, including CAR-T cell therapy, which harnesses the immune system to combat cancer more effectively. Recent advances include precision oncology, which tailors treatment based on genetic profiling of tumors, and nanomedicine enhancing drug delivery and targeting. Dr. Mridul suggests using liquid biopsies as a non-invasive cancer detection method. Also, there is gene therapy which is currently being explored to modify cancer cell behavior directly. These innovations are paving the way for more personalized and effective cancer care. Shocking! 27-year-old Mexican Influencer dies after liposuction procedure

World Cancer Day: Understanding different cancer therapies: Chemotherapy, Radiotherapy, and Surgery

A glass of milk each day holds the potential to improve bowel health, new research suggests. Watch this report for more details!

Glass of milk a day slashes bowel cancer risk by 17%: study

Veteran playback singer P Jayachandran died at 80, in Thrissur, Kerela. He was undergoing treatment for cancer. Watch this report for more details!

Veteran playback singer P Jayachandran dies at 80

A new study has shown that using artificial intelligence (AI) in breast cancer screening can help doctors detect more cases of the disease.&nbsp;
This is the first large-scale test of AI in a real-world screening programme, demonstrating that it can improve detection rates while not increasing false positives or unnecessary follow-up tests, as reported by The Guardian.
<h2>How the study was conducted&nbsp;</h2>
The study, which analysed data from 461,818 women in Germany who underwent breast cancer screenings between July 2021 and February 2023, tested AI in a national screening programme targeting asymptomatic women aged 50 to 69. Each woman's mammogram was reviewed by two radiologists, with AI being used to assist in the review process for half of the women. The AI tool flagged suspicious areas and alerted radiologists if they missed something.
Also Read | <a href="https://www.wionews.com/india-news/why-is-there-no-hmpv-vaccine-despite-the-viruss-discovery-24-years-ago-8598516">Why is there no HMPV vaccine despite the virus's discovery 24 years ago?</a>
<h2>AI boosts detection rates</h2>
According to the study published in the journal Nature Medicine, the results showed that women whose scans were assisted by AI had a 6.7 per cent higher breast cancer detection rate. After adjusting for factors like age and radiologist experience, the AI-assisted group detected 17.6 per cent more cancers. This means that one additional cancer case was found for every 1,000 women screened with AI.
Crucially, the AI tool did not lead to more false positives. This means women weren&rsquo;t sent for unnecessary follow-up tests. The AI&rsquo;s &ldquo;safety net&rdquo; function, which alerts radiologists when something suspicious is missed, led to 204 additional cancer diagnoses. Only 20 cancer cases would have been missed if radiologists had relied on their own assessments.
Also Read | <a href="https://www.wionews.com/science-tech/rabbit-fever-cases-surge-in-the-us-cdc-report-highlights-risks-8596988">Rabbit fever cases surge in the US: CDC report highlights risks</a>
<h2>Helping radiologists work more efficiently &nbsp;</h2>
The AI also helped reduce the workload of radiologists. Dr Stefan Bunk, co-author of the study and co-founder of Vara (the company behind the AI tool), explained that the AI allowed radiologists to review scans faster and focus on more complex cases.&nbsp;
<h2>Expert reactions</h2>
Experts have had mixed reactions to the findings. Dr Stephen Duffy, emeritus professor of cancer screening at Queen Mary University of London, praised the results but noted that further research is needed to determine whether AI could safely replace the two-radiologist system currently used in the UK.
Dr Kristina L&aring;ng from Lund University raised concerns about overdiagnosis, particularly regarding slow-growing tumours that may not need treatment. She emphasised the importance of long-term studies to ensure AI is identifying clinically significant cancers.
(With inputs from agencies)
&nbsp;

Science & Tech | World: This is the first large-scale test of AI in a real-world screening programme, demonstrating that it can improve detection rates while not increasing false positives or unnecessary follow-up tests.

A new study has shown that using artificial intelligence (AI) in breast cancer screening can help doctors detect more cases of the disease. This is the first large-scale test of AI in a real-world screening programme, demonstrating that it can improve detection rates while not increasing false positives or unnecessary follow-up tests, as reported by The Guardian. How the study was conducted The study, which analysed data from 461,818 women in Germany who underwent breast cancer screenings between July 2021 and February 2023, tested AI in a national screening programme targeting asymptomatic women aged 50 to 69. Each woman's mammogram was reviewed by two radiologists, with AI being used to assist in the review process for half of the women. The AI tool flagged suspicious areas and alerted radiologists if they missed something. Also Read | Why is there no HMPV vaccine despite the virus's discovery 24 years ago? AI boosts detection rates According to the study published in the journal Nature Medicine, the results showed that women whose scans were assisted by AI had a 6.7 per cent higher breast cancer detection rate. After adjusting for factors like age and radiologist experience, the AI-assisted group detected 17.6 per cent more cancers. This means that one additional cancer case was found for every 1,000 women screened with AI. Crucially, the AI tool did not lead to more false positives. This means women weren’t sent for unnecessary follow-up tests. The AI’s “safety net” function, which alerts radiologists when something suspicious is missed, led to 204 additional cancer diagnoses. Only 20 cancer cases would have been missed if radiologists had relied on their own assessments. Also Read | Rabbit fever cases surge in the US: CDC report highlights risks Helping radiologists work more efficiently The AI also helped reduce the workload of radiologists. Dr Stefan Bunk, co-author of the study and co-founder of Vara (the company behind the AI tool), explained that the AI allowed radiologists to review scans faster and focus on more complex cases. Expert reactions Experts have had mixed reactions to the findings. Dr Stephen Duffy, emeritus professor of cancer screening at Queen Mary University of London, praised the results but noted that further research is needed to determine whether AI could safely replace the two-radiologist system currently used in the UK. Dr Kristina Lång from Lund University raised concerns about overdiagnosis, particularly regarding slow-growing tumours that may not need treatment. She emphasised the importance of long-term studies to ensure AI is identifying clinically significant cancers. (With inputs from agencies)

New study shows AI helps find more cancer cases without causing extra harm

Is cancer a contagious disease that can spread through contact? No, not usually. However, a case being widely shared online shows that while this is very rare, it is not impossible to "catch" cancer from another person.
In what is believed to be the first-of-its-kind case, a doctor has caught a rare type of cancer while operating on a patient.
Also read | <a href="https://www.wionews.com/world/sunita-williams-witnesses-16-new-year-sunrises-science-explains-how-8582786" aria-label="Sunita Williams witnesses 16 New Year sunrises. Science explains how">Sunita Williams witnesses 16 New Year sunrises. Science explains how</a>
<h2>What happened?</h2>
The rare cancer transmission was originally reported in 1996 in the New England Journal of Medicine. Now, the medical anomaly has resurfaced.
While performing an operation to remove a tumour from a 32-year-old man's abdomen, a surgeon accidentally sliced the palm of his left hand and later developed a cancer that turned out to be genetically identical to his patient's. In the report, doctors described the case as an "accidental transplantation".
Also read | <a href="https://www.wionews.com/web-stories/science/exploring-the-science-of-why-certain-foods-make-us-happy-1732549040958" aria-label="Exploring the Science of Why Certain Foods Make Us Happy">Exploring the Science of Why Certain Foods Make Us Happy</a>
The surgeon, as per reports, was trying to place a drain in his patient when he accidentally cut his palm. The wound was immediately disinfected and bandaged. However, five months later, the 53-year-old surgeon noticed a small lump was developing at the site of the injury.
Upon testing, it was concluded that the 1.2-inch lump was a malignant fibrous histiocytoma tumour with cancer cells genetically identical to the patient. &nbsp;
<h2>How is that possible?</h2>
Normally, it is not possible. Usually, our body rejects any foreign tissue, however, as per the study authors, in this case, the surgeon's body had an "ineffective antitumour immune response".
Also read | <a href="https://www.wionews.com/web-stories/life-fun/health-and-wellness/why-do-you-feel-tired-all-the-time-as-per-science-1729152549643" aria-label="Why Do You Feel Tired All The Time, as per Science
">Why Do You Feel Tired All The Time, as per Science</a>
"In the case of the surgeon, an intense inflammatory reaction developed in the tissue surrounding the tumour, but the tumour mass increased, suggesting an ineffective antitumor immune response," they wrote.
They speculated that the tumour "escaped immunologic destruction through several mechanisms," and in this extremely rare case, the tumour transplantation was aided by a failure in the surgeon's body to detect and attack tumour cells effectively. There were no signs the cancer had returned or spread in the surgeon after he had the tumour removed.
(With inputs from agencies)

In what is believed to be the first-of-its-kind "accidental transplantation" case, a doctor caught a rare type of cancer while operating on a patient.

Is cancer a contagious disease that can spread through contact? No, not usually. However, a case being widely shared online shows that while this is very rare, it is not impossible to "catch" cancer from another person. In what is believed to be the first-of-its-kind case, a doctor has caught a rare type of cancer while operating on a patient. Also read | Sunita Williams witnesses 16 New Year sunrises. Science explains how What happened? The rare cancer transmission was originally reported in 1996 in the New England Journal of Medicine. Now, the medical anomaly has resurfaced. While performing an operation to remove a tumour from a 32-year-old man's abdomen, a surgeon accidentally sliced the palm of his left hand and later developed a cancer that turned out to be genetically identical to his patient's. In the report, doctors described the case as an "accidental transplantation". Also read | Exploring the Science of Why Certain Foods Make Us Happy The surgeon, as per reports, was trying to place a drain in his patient when he accidentally cut his palm. The wound was immediately disinfected and bandaged. However, five months later, the 53-year-old surgeon noticed a small lump was developing at the site of the injury. Upon testing, it was concluded that the 1.2-inch lump was a malignant fibrous histiocytoma tumour with cancer cells genetically identical to the patient. How is that possible? Normally, it is not possible. Usually, our body rejects any foreign tissue, however, as per the study authors, in this case, the surgeon's body had an "ineffective antitumour immune response". Also read | Why Do You Feel Tired All The Time, as per Science "In the case of the surgeon, an intense inflammatory reaction developed in the tissue surrounding the tumour, but the tumour mass increased, suggesting an ineffective antitumor immune response," they wrote. They speculated that the tumour "escaped immunologic destruction through several mechanisms," and in this extremely rare case, the tumour transplantation was aided by a failure in the surgeon's body to detect and attack tumour cells effectively. There were no signs the cancer had returned or spread in the surgeon after he had the tumour removed. (With inputs from agencies)

Can cancer be contagious? Surgeon 'catches' rare cancer from a patient

Alcoholic drinks should carry a label warning consumers about their cancer risks, the US Surgeon General said in an advisory on Friday, noting that their consumption increases the risk of developing breast, colon, liver and other cancers.
US Surgeon General Vivek Murthy also called for the guidelines on alcohol consumption limits to be reassessed so that people can weigh the cancer risk when deciding whether or how much to drink, alongside current warnings on birth defects and impairments when operating machinery.
<a href="https://www.wionews.com/world/four-including-australian-american-tourists-killed-in-alcohol-poisoning-incident-in-laos-777895" rel="dofollow">Also read: Laos alcohol poisoning incident: Death toll climbs to five</a>
Shares of US-listed alcoholic beverage makers fell between 1 per cent and 2 per cent in premarket trading, with Brown-Forman Corp leading the declines.
"Alcohol consumption is the third leading preventable cause of cancer in the United States, after tobacco and obesity, increasing risk for at least seven types of cancer," Murthy&rsquo;s office said in a statement accompanying the new report.
It is responsible for 100,000 US cancer cases and 20,000 cancer deaths each year, more than the 13,500 alcohol-associated traffic crash deaths, it added.
<a href="https://www.wionews.com/entertainment/hollywood/news-liam-payne-death-toxicology-report-reveals-he-had-cocaine-alcohol--antidepressants-in-his-system-774589" rel="dofollow">Also read: Liam Payne death: Toxicology report reveals he had cocaine, alcohol &amp; antidepressants in his system</a>
In the US, there are about 20,000 alcohol-related cancer deaths annually, according to the report.
Alcoholic beverages in the United States currently carry a health warning label that advises pregnant women to not drink them and that their consumption impairs a person&rsquo;s ability to drive a car or operate machinery.
This label has not changed since its inception in 1988.
"The direct link between alcohol consumption and cancer risk is well-established for at least seven types of cancer &hellip; regardless of the type of alcohol (e.g., beer, wine, and spirits) that is consumed," the statement said, including cancers of the esophagus, mouth, throat and voice box.
<a href="https://www.wionews.com/entertainment/lifestyle/news-alcohol-drinking-linked-to-risk-of-these-six-major-types-of-cancer-says-new-report-764077" rel="dofollow">Also read: Alcohol drinking linked to risk of these six major types of cancer, says new report</a>
The new report recommends health care providers should encourage alcohol screening and treatment referrals as needed, and efforts to increase general awareness should be expanded.
Disclaimer: This story has been published from a news agency feed with minimal edits to adhere to WION's style guide. The headline may have been changed to better reflect the content of the story or to make it more suitable for WION audience.

World: Shares of US-listed alcoholic beverage makers fell between 1 per cent and 2 per cent in premarket trading, with Brown-Forman Corp leading the declines.

Alcoholic drinks should carry a label warning consumers about their cancer risks, the US Surgeon General said in an advisory on Friday, noting that their consumption increases the risk of developing breast, colon, liver and other cancers. US Surgeon General Vivek Murthy also called for the guidelines on alcohol consumption limits to be reassessed so that people can weigh the cancer risk when deciding whether or how much to drink, alongside current warnings on birth defects and impairments when operating machinery. Also read: Laos alcohol poisoning incident: Death toll climbs to five Shares of US-listed alcoholic beverage makers fell between 1 per cent and 2 per cent in premarket trading, with Brown-Forman Corp leading the declines. "Alcohol consumption is the third leading preventable cause of cancer in the United States, after tobacco and obesity, increasing risk for at least seven types of cancer," Murthy’s office said in a statement accompanying the new report. It is responsible for 100,000 US cancer cases and 20,000 cancer deaths each year, more than the 13,500 alcohol-associated traffic crash deaths, it added. Also read: Liam Payne death: Toxicology report reveals he had cocaine, alcohol & antidepressants in his system In the US, there are about 20,000 alcohol-related cancer deaths annually, according to the report. Alcoholic beverages in the United States currently carry a health warning label that advises pregnant women to not drink them and that their consumption impairs a person’s ability to drive a car or operate machinery. This label has not changed since its inception in 1988. "The direct link between alcohol consumption and cancer risk is well-established for at least seven types of cancer … regardless of the type of alcohol (e.g., beer, wine, and spirits) that is consumed," the statement said, including cancers of the esophagus, mouth, throat and voice box. Also read: Alcohol drinking linked to risk of these six major types of cancer, says new report The new report recommends health care providers should encourage alcohol screening and treatment referrals as needed, and efforts to increase general awareness should be expanded. Disclaimer: This story has been published from a news agency feed with minimal edits to adhere to WION's style guide. The headline may have been changed to better reflect the content of the story or to make it more suitable for WION audience.

US surgeon general calls for cancer risk warnings on alcohol

Researchers in Korea have announced a groundbreaking advancement in cancer treatment, with a new therapy showing promise in reversing cancer progression. This innovative approach could offer new hope for patients and transform cancer treatment strategies globally.

Korea achieves breakthrough in cancer reversal therapy

Kannada actor Shiva Rajkumar has expressed gratitude to fans and well wishers after succesfully undergoing cancer treatment. The actor is one of Kannada film industry's top actors. On the first day of new year, the actor took to his official social media account to share a touching video, offering a glimpse of his emotional journey following his surgery in Miami, Florida.&nbsp;
In the video, Shiva Rajkumar shared his experience with fans and family as he reflected on his recovery. "Namaskar and wish you a Happy New Year," he began and stated that it has been a challenging to speak about his health. He admitted that even before his diagnosis, he had been fearful, but the unwavering support from his fans, family, and medical team gave him to fight through. "I was scared even before, but fans, relatives, co-artists, and doctors - especially Dr Shashidhar who treated me, and nurses made me strong. I did the chemotherapy, and honestly, I don't know how I managed. But in the end, when I was ready to go for treatment in Miami, I was still scared. However, my friends, family, and loved ones were by my side," Rajkumar shared. The actor thanked his wife and others who have stood by him through this difficult journey. "My cousin, wife Geetha, Prashant, my friend Anu, and Madhu Bangarappa took great care of me. Doctors and the entire staff at the Miami Cancer Center were extremely supportive," he said, adding that the surgery had been successful.
<blockquote class="twitter-tweet">
ನಿಮ್ಮೆಲ್ಲರ ಪ್ರೀತಿ, ಆಶೀರ್ವಾದಕ್ಕೆ ನಾನು ಚಿರಋಣಿ ಹೊಸ ವರ್ಷದ ಹಾರ್ದಿಕ ಶುಭಾಶಯಗಳು! #2025 <a href="https://t.co/4oyg2uXfjg">pic.twitter.com/4oyg2uXfjg</a>
&mdash; DrShivaRajkumar (@NimmaShivanna) <a href="https://twitter.com/NimmaShivanna/status/1874347791109284086?ref_src=twsrc%5Etfw">January 1, 2025</a></blockquote>

<script async="" src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

"The kidney bladder was removed, and a new one was put in place. With all your wishes and the doctor's advice, I'll be taking care of myself for the next month. I will be back stronger soon. Love you all, and Happy New Year," he wrote.
<a href="https://www.wionews.com/entertainment/siima-2024-full-winners-list-aishwarya-rai-bachchan-chiyaan-vikram-and-more-759115">SIIMA 2024 full winners list: Aishwarya Rai Bachchan, Chiyaan Vikram and more</a>
His wife, Geetha Shivarajkumar, also shared a message of gratitude, revealing the positive outcome of Shiva Rajkumar's medical journey. "Wishing you all a Happy New Year! With your blessings, all the reports have come back negative. We were anxiously awaiting the pathology report, and it has been officially confirmed that Shiva Rajkumar is cancer-free," she shared, adding, "We'll never forget your love and wishes. I thank you all from the bottom of my heart."
n his social media post, Shiva Rajkumar captioned the video, expressing deep appreciation for the support he had received throughout his recovery. "I am eternally grateful for all your love and blessings. Happy New Year! #2025."
The 62-year-old actor successfully underwent surgery for bladder cancer at the Miami Cancer Institute in December.
<a href="https://www.wionews.com/entertainment/death-threats-to-oscar-tussle-the-biggest-controversies-of-showbiz-in-2024-8581259">Death threats to Oscar tussle: The biggest controversies of showbiz in 2024</a>
Rajkumar, who is the older brother of late actor Puneeth Rajkumar, has been a key figure in the Kannada film industry for decades.
The news of his recovery has brought immense joy to his fans, who had been praying for his swift return to health.

Shiva Rajkumar has expressed gratitude to fans and well wishers after succesfully undergoing cancer treatment. The actor is one of Kannada film industry's top actors. 

Kannada actor Shiva Rajkumar has expressed gratitude to fans and well wishers after succesfully undergoing cancer treatment. The actor is one of Kannada film industry's top actors. On the first day of new year, the actor took to his official social media account to share a touching video, offering a glimpse of his emotional journey following his surgery in Miami, Florida. In the video, Shiva Rajkumar shared his experience with fans and family as he reflected on his recovery. "Namaskar and wish you a Happy New Year," he began and stated that it has been a challenging to speak about his health. He admitted that even before his diagnosis, he had been fearful, but the unwavering support from his fans, family, and medical team gave him to fight through. "I was scared even before, but fans, relatives, co-artists, and doctors - especially Dr Shashidhar who treated me, and nurses made me strong. I did the chemotherapy, and honestly, I don't know how I managed. But in the end, when I was ready to go for treatment in Miami, I was still scared. However, my friends, family, and loved ones were by my side," Rajkumar shared. The actor thanked his wife and others who have stood by him through this difficult journey. "My cousin, wife Geetha, Prashant, my friend Anu, and Madhu Bangarappa took great care of me. Doctors and the entire staff at the Miami Cancer Center were extremely supportive," he said, adding that the surgery had been successful. ನಿಮ್ಮೆಲ್ಲರ ಪ್ರೀತಿ, ಆಶೀರ್ವಾದಕ್ಕೆ ನಾನು ಚಿರಋಣಿ ಹೊಸ ವರ್ಷದ ಹಾರ್ದಿಕ ಶುಭಾಶಯಗಳು! #2025 pic.twitter.com/4oyg2uXfjg — DrShivaRajkumar (@NimmaShivanna) January 1, 2025 "The kidney bladder was removed, and a new one was put in place. With all your wishes and the doctor's advice, I'll be taking care of myself for the next month. I will be back stronger soon. Love you all, and Happy New Year," he wrote. SIIMA 2024 full winners list: Aishwarya Rai Bachchan, Chiyaan Vikram and more His wife, Geetha Shivarajkumar, also shared a message of gratitude, revealing the positive outcome of Shiva Rajkumar's medical journey. "Wishing you all a Happy New Year! With your blessings, all the reports have come back negative. We were anxiously awaiting the pathology report, and it has been officially confirmed that Shiva Rajkumar is cancer-free," she shared, adding, "We'll never forget your love and wishes. I thank you all from the bottom of my heart." n his social media post, Shiva Rajkumar captioned the video, expressing deep appreciation for the support he had received throughout his recovery. "I am eternally grateful for all your love and blessings. Happy New Year! #2025." The 62-year-old actor successfully underwent surgery for bladder cancer at the Miami Cancer Institute in December. Death threats to Oscar tussle: The biggest controversies of showbiz in 2024 Rajkumar, who is the older brother of late actor Puneeth Rajkumar, has been a key figure in the Kannada film industry for decades. The news of his recovery has brought immense joy to his fans, who had been praying for his swift return to health.

Kannada actor Shiva Rajkumar reveals he is cancer-free in new video, expresses gratitude to fans

If you enjoy sipping on a mug of tea or coffee, here's some interesting news for you: these hot drinks might do more than just keep you warm in winter. They could actually help lower the risk of head and neck cancers. A study analyzing data from nearly 25,000 people across Europe, North America, and Latin America found some promising links. Coffee drinkers who consume four or more cups a day had a 17% lower risk of head and neck cancers overall, particularly cancers of the mouth and throat. Even decaf coffee showed benefits, especially for oral cancer. Watch in for more details!

Study Says Coffee Lovers Have Lower Risk Of Head & Neck Cancers

If you enjoy sipping on a mug of tea or coffee, here's some interesting news for you: these hot drinks might do more than just keep you warm in winter. They could actually help lower the risk of head and neck cancers. A study analyzing data from nearly 25,000 people across Europe, North America, and Latin America found some promising links. Coffee drinkers who consume four or more cups a day had a 17% lower risk of head and neck cancers overall, particularly cancers of the mouth and throat. Even decaf coffee showed benefits, especially for oral cancer. Watch in for more details!



A new study suggests that drinking tea or coffee daily may lower the risk for several cancer types. Watch this report for more details!

Drinking Tea or Coffee Each Day Could Lower Cancer Risk

As per a new study, the food you are consuming may have been badly affecting the ability of the body to fight cancer cells present in the colon. The overconsumption of a certain kind of omega-6 fatty acids, which is most probably becoming a part of the diet because of ultra-processed foods, is most likely hindering tumour-fighting and anti-inflammatory properties of essential fatty acid omega-3.

As per a new study, the food you are consuming may have been badly affecting the ability of the body to fight cancer cells present in the colon. The overconsumption of a certain kind of omega-6 fatty acids, which is most probably becoming a part of the diet because of ultra-processed foods, is most likely hindering tumour-fighting and anti-inflammatory properties of essential fatty acid omega-3. “There are mutations every day in the GI (gastrointestinal) tract, and normally they’re quashed right away by the immune system with the help of molecules or mediators from omega-3s,” said Dr Timothy Yeatman, who is the study's senior co-author which was published on Tuesday (Dec 10). Also Read: Killer dumplings? Woman dies after eating momo, 15 others suffer food poisoning The study has been published in Gut, the journal of the British Society of Gastroenterology . “But if you have a body subjected to years of a chronic inflammatory milieu created by an imbalance of omega-6s, the type commonly found in ultra-processed and junk foods, I believe it’s easier for a mutation to take hold and harder for the body to fight it,” said Yeatman, who is a professor at the Tampa General Hospital Cancer Institute. Omega-6 fatty acids dominate the Western diet? As per experts, a Western diet is filled with omega-6 fatty acids because of seed oils used to prepare it and 70 per cent of the food supply in the United States is dominated by ultra-processed foods. Watch: UK Government's Restriction On Junk Food Advertisements Before 9 PM Linoleic acid, which is an omega-6 fatty acid that is available in sunflower, corn, peanut, soybean and safflower oils, is the most common omega-6 present in the food supply of the US. “It’s a leap to say that omega-6s from ultra-processed foods are the cause. Americans have few omega-3s because they dislike fatty fish such as mackerel, herring and sardines, which are great sources,” said Dr. Bill Harris, who is a professor at the University of South Dakota, while speaking to CNN. “Don’t blame the omega-6s, it’s not their fault — it’s the lack of omega-3 fatty acids that’s the problem,” he added. (With inputs from agencies)

Omega-6 fatty acid decreasing ability to fight against cancer cells, warns study

Former cricketer and politician Navjot Singh Sidhu is under fire for his recent remarks about his wife's recovery from stage four breast cancer. His statements have drawn sharp criticism from leading oncologists across India who warn that such claims could mislead vulnerable patients.

Sidhu Peddling Prejudice on Cancer | GRAVITAS

Red wine may be good for you. As per scientists, a compound found in red wine could hold the key to preventing bowel cancer. However, a trial launched this week is yet to assess whether a low dose of the said chemical also found in red grapes, blueberries, and peanuts could actually slow the growth of tumour cells in the gut.

New Trial in UK to Assess if Chemical Found in Red Grape Can Prevent Bowel Cancer | GRAVITAS

A new radioactive therapy is being credited for the shrinking of a man's brain tumour by half in weeks. Will this prove to be a game changer in the fight against cancer? Molly Gambhir tells you more.

New Therapy Shrinks Man's Brain Tumour by Half in Weeks

British pharmaceutical company GSK has agreed to pay $2.3 billion to settle lawsuits alleging that its heart burn medication Zantac caused cancer. GSK has settled 80,000 Zantac lawsuit. Watch to know more.

Pharmaceutical Giant GSK Reaches Major Settlement

The government of the United Kingdom is likely to introduce a new 'game-changing' blood test which will be able to detect signs of the 12 most common&nbsp;cancers before patients develop any symptoms.

Health Secretary&nbsp;Wes Streeting, who is himself a cancer&nbsp;survivor, will introduce the government-funded 'universal' blood screening for treating the disease in five years.

<h2>All about the innovative blood test&nbsp;</h2>

The treatment is a type of PCR test which is used during the pandemic and it can increase survival chances and save many lives every year.

The development comes after a blood test was hailed by the doctors in June in which they can predict if there are chances of breast cancer relapsing before it appears on the scans.

Also Read:&nbsp;<a href="https://www.wionews.com/entertainment/lifestyle/news-lifestyle-changes-that-may-help-in-lowering-the-chances-of-breast-cancer-764806">Lifestyle changes that may help in lowering the chances of breast cancer</a>

Speaking to The Mirror, Streeting said, "Just a couple of drops of blood could tell you if you had lung, breast or bladder cancer, helping end months-long waits for tests and scans. These innovations could be game changers."

This test will cost each patient £120 (approx. $157) and will check the 12 most common cancers which are lung, breast, prostate, pancreatic, colorectal, ovarian, liver, brain, oesophageal, bladder, bone and soft tissue sarcoma, and gastric.

The scheme has been provided £2.5 million ($3.28&nbsp;million) worth of funding by the UK government through the National Institute for Health and Care Research.

Watch:&nbsp;Kate Middleton Hugs Young Girl Battling Rare Cancer

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/kate-middleton-hugs-young-girl-battling-rare-cancer-764144/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

A startup company Xgenera has been set up by the scientists to help the scheme in rolling out, which they claimed has "potential to save millions of lives".&nbsp;

Every year, more than 320,000 people are diagnosed with prostate, breast, bowel and lung cancers.

According to experts, nearly 40,000 cancers had gone undiagnosed in the first year of the pandemic.

As of now, screening programmes are among the most effective ways of detecting early-stage cancers.

(With inputs from agencies)

The government of the United Kingdom is likely to introduce a new 'game-changing' blood test which will be able to detect signs of the 12 most common cancers before patients develop any symptoms.

The government of the United Kingdom is likely to introduce a new 'game-changing' blood test which will be able to detect signs of the 12 most common cancers before patients develop any symptoms. Health Secretary Wes Streeting, who is himself a cancer survivor, will introduce the government-funded 'universal' blood screening for treating the disease in five years. All about the innovative blood test The treatment is a type of PCR test which is used during the pandemic and it can increase survival chances and save many lives every year. The development comes after a blood test was hailed by the doctors in June in which they can predict if there are chances of breast cancer relapsing before it appears on the scans. Also Read: Lifestyle changes that may help in lowering the chances of breast cancer Speaking to The Mirror, Streeting said, "Just a couple of drops of blood could tell you if you had lung, breast or bladder cancer, helping end months-long waits for tests and scans. These innovations could be game changers." This test will cost each patient £120 (approx. $157) and will check the 12 most common cancers which are lung, breast, prostate, pancreatic, colorectal, ovarian, liver, brain, oesophageal, bladder, bone and soft tissue sarcoma, and gastric. The scheme has been provided £2.5 million ($3.28 million) worth of funding by the UK government through the National Institute for Health and Care Research. Watch: Kate Middleton Hugs Young Girl Battling Rare Cancer A startup company Xgenera has been set up by the scientists to help the scheme in rolling out, which they claimed has "potential to save millions of lives". Every year, more than 320,000 people are diagnosed with prostate, breast, bowel and lung cancers. According to experts, nearly 40,000 cancers had gone undiagnosed in the first year of the pandemic. As of now, screening programmes are among the most effective ways of detecting early-stage cancers. (With inputs from agencies)

A new 'game-changing' blood test will detect 12 types of cancers. Here's all about it

cancer

Cancer, News on Cancer, stories on Cancer, articles on Cancer, Cancer stories at Wion, Cancer news, Cancer latest news